Clinical trial
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
NCT06318442
Study timeline
Study start (actual)2024-05-15Date precision: day
Registry last updated2024-10-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Steroid-Induced Diabetesunresolved
Steroid Induced Hyperglycemiaunresolved
Interventions
Metformin Oral TabletDRUG · verified · RxNorm: metformin Oral Tablet
PlaceboDRUG
Sponsors & collaborators
Imperial College Londonlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06318442 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.